https://www.pacificbridgemedical.com/news-brief/taiwan-tightens-focus-on-ai-devices/ 2026-07-31T19:14:17+00:00 https://www.pacificbridgemedical.com/news-brief/japans-medical-device-market-2026-big-opportunity-tighter-reimbursement/ 2026-07-31T19:14:09+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-drug-regulator-moves-to-fast-track-cell-and-gene-therapy-reviews/ 2026-07-31T19:13:52+00:00 https://www.pacificbridgemedical.com/news-brief/india-finalizes-comprehensive-guidance-on-medical-device-software/ 2026-07-31T19:13:41+00:00 https://www.pacificbridgemedical.com/news-brief/japan-and-us-open-talks-on-drug-gmp-manufacturing-inspection-deal/ 2026-07-31T19:13:28+00:00 https://www.pacificbridgemedical.com/news-brief/korea-regulatory-updates-august-2026/ 2026-07-31T19:13:13+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-august-2026/ 2026-07-31T19:12:58+00:00 https://www.pacificbridgemedical.com/news-brief/japan-eases-repurposed-drug-and-sakigake-filing-rules/ 2026-07-31T19:12:40+00:00 https://www.pacificbridgemedical.com/news-brief/china-wraps-up-preliminary-review-for-2026-drug-list-adjustments/ 2026-07-31T19:12:25+00:00 https://www.pacificbridgemedical.com/news-brief/japan-to-strengthen-rewards-for-innovative-medicines-in-key-policy-document/ 2026-07-31T19:12:16+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-july-2026/ 2026-07-06T21:00:23+00:00 https://www.pacificbridgemedical.com/news-brief/china-updates-good-clinical-practice-requirements-for-drug-clinical-trials/ 2026-07-06T21:00:13+00:00 https://www.pacificbridgemedical.com/news-brief/china-revises-drug-administration-law-implementing-provisions/ 2026-07-06T20:59:48+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-updates-rules-for-drug-promotion-and-advertising/ 2026-07-06T20:59:27+00:00 https://www.pacificbridgemedical.com/news-brief/china-clarifies-requirements-for-medical-device-classification-changes/ 2026-07-06T20:59:02+00:00 https://www.pacificbridgemedical.com/news-brief/japan-warns-that-proposed-us-drug-pricing-policy-threatens-drug-market-access/ 2026-07-06T20:58:52+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-updates-essential-document-requirements-for-medical-device-listings/ 2026-07-06T20:58:40+00:00 https://www.pacificbridgemedical.com/news-brief/quick-japan-regulatory-updates-july-2026/ 2026-07-06T20:58:27+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-tightens-medical-software-rules-with-udi-requirement/ 2026-07-06T20:58:12+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-to-streamline-approval-of-innovative-drugs-and-medical-devices/ 2026-07-06T20:57:53+00:00 https://www.pacificbridgemedical.com/news-brief/japan-registering-ai-based-medical-devices/ 2026-06-02T13:27:48+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-to-implement-revised-medical-device-qms-requirements/ 2026-06-02T13:27:28+00:00 https://www.pacificbridgemedical.com/news-brief/japan-clarifies-revised-conditional-drug-approval-framework/ 2026-06-02T13:27:14+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-june-2026/ 2026-06-02T13:26:58+00:00 https://www.pacificbridgemedical.com/news-brief/china-proposes-new-drug-reimbursement-rules-and-pediatric-medicine-reforms/ 2026-06-02T13:26:30+00:00 https://www.pacificbridgemedical.com/news-brief/japan-announces-mixed-drug-price-revisions-for-fy2026/ 2026-06-02T13:25:45+00:00 https://www.pacificbridgemedical.com/news-brief/korea-accelerates-review-pathways-for-innovative-drugs-and-medical-devices/ 2026-06-02T13:25:21+00:00 https://www.pacificbridgemedical.com/news-brief/china-cracks-down-on-medical-insurance-fraud/ 2026-06-02T13:25:02+00:00 https://www.pacificbridgemedical.com/news-brief/japans-pmda-launches-new-orphan-drug-designation-resource-page/ 2026-06-02T13:24:49+00:00 https://www.pacificbridgemedical.com/news-brief/india-strengthens-quality-surveillance-for-medical-devices-and-pharmaceuticals/ 2026-06-02T13:23:52+00:00 https://www.pacificbridgemedical.com/news-brief/japan-releases-english-version-for-remote-gcp-drug-and-regenerative-product-inspections/ 2026-05-28T20:55:57+00:00 https://www.pacificbridgemedical.com/news-brief/japan-qms-update/ 2026-05-28T20:55:19+00:00 https://www.pacificbridgemedical.com/news-brief/japan-expands-its-orphan-drug-designation-system/ 2026-05-28T20:54:16+00:00 https://www.pacificbridgemedical.com/news-brief/japan-continues-its-efforts-to-boost-its-drug-market/ 2026-05-28T20:53:43+00:00 https://www.pacificbridgemedical.com/news-brief/indonesia-introduces-updates-to-medical-device-accessories-rules-e-registration-system/ 2026-05-28T20:53:12+00:00 https://www.pacificbridgemedical.com/news-brief/indias-new-online-submission-system-for-clinical-trial-applications/ 2026-05-28T20:45:51+00:00 https://www.pacificbridgemedical.com/news-brief/india-plans-to-increase-its-medical-device-production/ 2026-05-28T20:45:32+00:00 https://www.pacificbridgemedical.com/news-brief/india-plans-comprehensive-drug-database/ 2026-05-19T20:54:17+00:00 https://www.pacificbridgemedical.com/news-brief/india-moves-to-regulate-the-sale-of-medical-devices-to-better-monitor-quality/ 2026-05-19T20:53:55+00:00 https://www.pacificbridgemedical.com/news-brief/india-adds-new-drugs-to-essential-medicines-list/ 2026-05-19T20:53:16+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-to-introduce-conformity-assessment-framework-for-medical-devices/ 2026-05-19T20:52:50+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-starts-class-d-ivd-medical-device-listing-in-december-2009/ 2026-05-19T20:52:33+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-new-listing-system-for-medical-devices/ 2026-05-19T20:52:17+00:00 https://www.pacificbridgemedical.com/news-brief/china-clinical-trial-requirements-simplified-for-certain-class-ii-devices/ 2026-05-19T20:50:59+00:00 https://www.pacificbridgemedical.com/news-brief/china-approves-new-regulations-releases-new-drafts-and-standards/ 2026-05-19T20:50:38+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-new-software-regulations/ 2026-05-19T20:50:08+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-new-guidelines-on-medical-device-manufacturing/ 2026-05-19T20:49:38+00:00 https://www.pacificbridgemedical.com/news-brief/china-nmpa-outlines-plan-to-integrate-ai/ 2026-05-04T19:01:51+00:00 https://www.pacificbridgemedical.com/news-brief/japan-introduces-new-mechanisms-to-increase-recruitment-for-clinical-trials/ 2026-05-04T18:58:40+00:00 https://www.pacificbridgemedical.com/news-brief/korea-launches-funding-program-to-accelerate-ai-medical-device-commercialization/ 2026-05-04T18:58:05+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-introduces-new-post-market-surveillance-requirements-for-medical-devices/ 2026-05-04T18:57:11+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-may-2026/ 2026-05-04T18:56:02+00:00 https://www.pacificbridgemedical.com/news-brief/japan-and-singapore-strengthen-regulatory-cooperation-to-streamline-access-to-drugs/ 2026-05-04T18:55:47+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-begins-new-drug-review-pathway/ 2026-05-04T18:55:36+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-issues-cybersecurity-and-data-security-guidelines-for-the-healthcare-sector/ 2026-05-04T18:54:52+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-consolidates-medical-device-rules/ 2026-05-04T18:54:42+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-proposes-new-post-market-surveillance-rules-for-medical-devices/ 2026-05-04T18:54:15+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-updates-pediatric-drug-development-guidance/ 2026-03-31T20:36:06+00:00 https://www.pacificbridgemedical.com/news-brief/korea-introduces-regulatory-reforms-for-medical-device-change-management/ 2026-03-31T20:36:01+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-april-2026/ 2026-03-31T20:35:58+00:00 https://www.pacificbridgemedical.com/news-brief/china-introduces-market-and-data-exclusivity-in-major-drug-regulatory-reform/ 2026-03-31T20:35:43+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-initiates-early-regulatory-review-for-innovative-medical-devices/ 2026-03-31T20:35:39+00:00 https://www.pacificbridgemedical.com/news-brief/korea-fast-tracks-reimbursement-for-rare-disease-therapies-to-boost-patient-access/ 2026-03-31T20:35:12+00:00 https://www.pacificbridgemedical.com/news-brief/china-expands-udi-requirements-for-class-ii-medical-devices-in-2027/ 2026-03-31T20:34:57+00:00 https://www.pacificbridgemedical.com/news-brief/korea-advances-ai-driven-drug-review-while-attracting-global-biopharma-investment/ 2026-03-31T20:34:46+00:00 https://www.pacificbridgemedical.com/news-brief/japan-moves-to-boost-drug-development-and-address-shortages/ 2026-03-31T20:34:44+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-strengthens-guidelines-for-drug-product-defects-and-recalls/ 2026-03-31T20:34:22+00:00 https://www.pacificbridgemedical.com/news-brief/quick-china-regulatory-updates-march-2026/ 2026-03-03T14:07:03+00:00 https://www.pacificbridgemedical.com/news-brief/japan-moves-to-address-drug-gaps-and-support-overseas-biopharma-trials/ 2026-03-02T20:55:37+00:00 https://www.pacificbridgemedical.com/news-brief/china-tightens-contract-drug-manufacturing-rules/ 2026-03-02T20:53:13+00:00 https://www.pacificbridgemedical.com/news-brief/japan-clarifies-procedures-for-medical-device-raw-material-changes/ 2026-03-02T20:52:52+00:00 https://www.pacificbridgemedical.com/news-brief/cdsco-streamlines-medical-device-reviews-through-stricter-response-timelines-and-pre-filing-guidance/ 2026-03-02T20:52:34+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-march-2026/ 2026-03-02T20:51:25+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-issues-medical-device-labeling-regulation/ 2026-03-02T20:50:37+00:00 https://www.pacificbridgemedical.com/news-brief/korea-expands-expedited-review-for-orphan-drugs/ 2026-03-02T20:50:19+00:00 https://www.pacificbridgemedical.com/news-brief/hsa-confirms-framework-for-ai-samd-regulatory-sandbox-in-singapore/ 2026-03-02T20:49:49+00:00 https://www.pacificbridgemedical.com/news-brief/india-eyes-regulatory-sandbox-model-to-speed-pharma-approvals/ 2026-03-02T20:49:30+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-medical-device-regulatory-updates-february-2026/ 2026-02-02T21:31:13+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-lower-import-tariffs-on-select-medical-products-in-2026/ 2026-02-02T21:14:09+00:00 https://www.pacificbridgemedical.com/news-brief/japan-issues-new-pricing-rules-for-conditionally-approved-regenerative-medicines/ 2026-02-02T21:13:53+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-february-2026/ 2026-02-02T21:13:22+00:00 https://www.pacificbridgemedical.com/news-brief/china-finalizes-2025-national-reimbursement-drug-list-and-launches-first-commercial-insurance-drug-list/ 2026-02-02T21:12:26+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-published-draft-change-management-guidance-for-medical-devices/ 2026-02-02T21:10:42+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-updates-therapeutic-product-registration-rules/ 2026-02-02T21:09:58+00:00 https://www.pacificbridgemedical.com/news-brief/indias-health-ministry-halves-clinical-trial-approval-timeline-for-drugs-to-45-days/ 2026-02-02T21:09:43+00:00 https://www.pacificbridgemedical.com/news-brief/clinical-trials-in-asia-gain-momentum/ 2026-02-02T21:09:19+00:00 https://www.pacificbridgemedical.com/news-brief/china-revises-pharmaceutical-implementing-regulations-to-boost-innovation-and-market-access/ 2026-02-02T21:08:22+00:00 https://www.pacificbridgemedical.com/news-brief/is-china-still-a-big-opportunity-for-western-healthcare-companies/ 2026-01-07T19:50:10+00:00 https://www.pacificbridgemedical.com/news-brief/china-nmpa-issues-medical-device-sampling-plan/ 2026-01-07T19:47:33+00:00 https://www.pacificbridgemedical.com/news-brief/china-medical-device-update/ 2026-01-07T19:38:25+00:00 https://www.pacificbridgemedical.com/news-brief/china-allows-overseas-labs-for-self-testing-for-medical-device-approval/ 2026-01-07T19:36:17+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-and-china-launch-medical-device-regulatory-reliance-program/ 2026-01-07T19:23:09+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-new-strategic-policy-boosts-medtech-innovation/ 2026-01-07T19:00:44+00:00 https://www.pacificbridgemedical.com/news-brief/china-implements-regulations-on-medical-device-self-testing/ 2026-01-07T18:59:47+00:00 https://www.pacificbridgemedical.com/news-brief/china-amends-good-manufacturing-practice-for-medical-devices/ 2026-01-07T18:56:58+00:00 https://www.pacificbridgemedical.com/news-brief/korea-and-china-accelerate-support-for-medical-device-innovation/ 2026-01-07T18:51:47+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-and-thailand-launch-medical-device-regulatory-reliance-pilot/ 2025-12-23T17:05:37+00:00 https://www.pacificbridgemedical.com/news-brief/japan-to-introduce-pathway-for-specific-use-drug-designations/ 2025-12-23T17:05:19+00:00 https://www.pacificbridgemedical.com/news-brief/china-adds-55-drugs-to-the-new-11th-vbp-round-tightens-rules-on-quality-and-supply-stability/ 2025-12-23T17:03:14+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-and-the-uk-initiate-fast-track-regulatory-pathway-for-breakthrough-health-technologies/ 2025-12-23T17:01:04+00:00 https://www.pacificbridgemedical.com/news-brief/korea-eases-path-to-breakthrough-drugs-with-flexible-incremental-cost-effectiveness-ratio/ 2025-12-23T17:00:54+00:00 https://www.pacificbridgemedical.com/news-brief/china-tightens-oversight-of-excessive-prescribing-raising-risks-for-multinational-drug-companies/ 2025-12-23T17:00:54+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-initiates-health-information-bill/ 2025-12-23T17:00:51+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates-january-2026/ 2025-12-23T17:00:48+00:00 https://www.pacificbridgemedical.com/news-brief/korea-starts-reforms-to-fast-track-healthcare-approvals-and-improve-rare-disease-access/ 2025-12-23T17:00:43+00:00 https://www.pacificbridgemedical.com/news-brief/japan-medical-device-reimbursement-getting-tougher/ 2025-12-18T16:41:42+00:00 https://www.pacificbridgemedical.com/news-brief/india-releases-draft-guidance-on-medical-device-software/ 2025-12-02T14:14:31+00:00 https://www.pacificbridgemedical.com/news-brief/japans-samd-market-poised-for-rapid-expansion/ 2025-11-30T21:47:10+00:00 https://www.pacificbridgemedical.com/news-brief/china-issues-new-draft-revision-good-clinical-practice-for-drugs/ 2025-11-30T21:44:39+00:00 https://www.pacificbridgemedical.com/news-brief/japan-drug-price-negotiations-continue-for-fy2026/ 2025-11-30T21:42:28+00:00 https://www.pacificbridgemedical.com/news-brief/china-introduces-new-rules-to-regulate-cutting-edge-biomedical-technologies/ 2025-11-30T21:35:28+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-december-2025/ 2025-11-30T21:33:34+00:00 https://www.pacificbridgemedical.com/news-brief/some-innovative-western-devices-pause-before-japan-entry/ 2025-11-30T21:31:55+00:00 https://www.pacificbridgemedical.com/news-brief/korea-expands-access-to-cancer-clinical-trials-for-early-stage-patients/ 2025-11-30T21:29:10+00:00 https://www.pacificbridgemedical.com/news-brief/india-clarifies-packaging-rules-for-medical-devices/ 2025-11-30T21:26:48+00:00 https://www.pacificbridgemedical.com/news-brief/korea-to-now-unveil-full-drug-gmp-inspection-results/ 2025-11-04T16:45:48+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-updates-on-telemedicine-and-advertising/ 2025-11-04T00:29:41+00:00 https://www.pacificbridgemedical.com/news-brief/indonesias-halal-certification-deadlines/ 2025-11-04T00:28:44+00:00 https://www.pacificbridgemedical.com/news-brief/the-malaysia-medical-device-authority-mda-issues-new-regulation-to-expedite-product-registration/ 2025-11-04T00:28:08+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-november-2025/ 2025-11-04T00:27:10+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-extensively-revise-drug-quality-standards/ 2025-11-04T00:26:40+00:00 https://www.pacificbridgemedical.com/news-brief/japan-debating-many-drug-reimbursement-issues-now-for-fy-2026/ 2025-11-04T00:25:21+00:00 https://www.pacificbridgemedical.com/news-brief/china-promulgates-30-day-ind-pathway-for-innovative-drugs/ 2025-11-04T00:23:30+00:00 https://www.pacificbridgemedical.com/news-brief/japan-dramatically-increasing-its-drug-gmp-inspections/ 2025-09-24T18:06:14+00:00 https://www.pacificbridgemedical.com/news-brief/taiwans-fda-releases-updated-guidelines-for-ai-medical-devices/ 2025-09-24T17:38:45+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-2025-drug-reimbursement-update-innovation-and-competition/ 2025-09-24T17:38:36+00:00 https://www.pacificbridgemedical.com/news-brief/thailand-fda-streamlines-renewal-process-for-class-2-3-and-4-medical-devices/ 2025-09-24T17:38:27+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-october-2025/ 2025-09-24T17:38:16+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-implements-revisions-to-clinical-trial-policies-to-streamline-development/ 2025-09-24T17:38:05+00:00 https://www.pacificbridgemedical.com/news-brief/india-seeks-to-relax-clinical-trial-guidelines/ 2025-09-24T17:37:53+00:00 https://www.pacificbridgemedical.com/news-brief/korea-regulatory-updates-october-2025/ 2025-09-24T17:37:44+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-to-use-real-world-evidence-in-drug-listing-decisions/ 2025-09-24T17:37:33+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates-october-2025/ 2025-09-24T17:37:23+00:00 https://www.pacificbridgemedical.com/news-brief/japan-singapore-singapore-malaysia-advance-cross-border-regulatory-cooperation-on-medical-products/ 2025-09-02T18:25:48+00:00 https://www.pacificbridgemedical.com/news-brief/india-announces-first-formal-guidelines-to-simplify-drug-and-device-approvals/ 2025-09-02T18:24:24+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-updates-guidance-regarding-software-as-a-medical-device-and-clinical-decision-support-software/ 2025-09-02T17:47:33+00:00 https://www.pacificbridgemedical.com/news-brief/japans-mhlw-announces-increased-fy2026-budget/ 2025-09-02T17:45:43+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-updates-regulatory-guidance-for-therapeutic-drug-registration/ 2025-09-02T00:05:02+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-and-device-regulatory-updates-september-2025/ 2025-09-02T00:00:19+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-ai-drug-companies-secure-multibillion-dollar-big-pharma-partnerships/ 2025-09-01T23:58:08+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates-september-2025/ 2025-09-01T23:55:43+00:00 https://www.pacificbridgemedical.com/news-brief/japan-plans-to-moderate-its-recruiting-regulations-for-clinical-trials/ 2025-07-31T13:26:10+00:00 https://www.pacificbridgemedical.com/news-brief/japan-now-looking-to-promote-a-single-irb-for-multi-center-studies/ 2025-07-31T13:15:06+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-august-2025/ 2025-07-30T20:52:33+00:00 https://www.pacificbridgemedical.com/news-brief/korea-adopts-ai-use-in-drug-review-and-safety-monitoring/ 2025-07-30T20:51:19+00:00 https://www.pacificbridgemedical.com/news-brief/china-drug-market-access-update-august-2025/ 2025-07-30T20:49:55+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-updates-august-2025/ 2025-07-30T20:46:56+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-promulgates-new-decree-as-part-of-amended-law-on-pharmacy/ 2025-07-30T20:45:21+00:00 https://www.pacificbridgemedical.com/news-brief/india-medical-device-update-august-2025/ 2025-07-30T20:38:35+00:00 https://www.pacificbridgemedical.com/news-brief/china-announces-new-policy-to-support-innovative-drug-development/ 2025-07-30T20:35:34+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-seeks-feedback-on-ai-samd-regulatory-exemption-for-public-healthcare-use/ 2025-07-07T19:27:19+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-hsa-launches-new-platform-for-medical-device-submissions/ 2025-07-07T19:27:03+00:00 https://www.pacificbridgemedical.com/news-brief/quick-japan-regulatory-updates/ 2025-07-07T18:40:52+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-nmpa-issues-new-guideline-on-ngs-based-ivd-reagent-classification/ 2025-07-07T18:23:54+00:00 https://www.pacificbridgemedical.com/news-brief/hong-kong-will-soon-launch-independent-drug-review-system/ 2025-07-07T18:23:38+00:00 https://www.pacificbridgemedical.com/news-brief/japan-starts-to-utilize-ai-to-boost-pharma/ 2025-07-07T18:23:30+00:00 https://www.pacificbridgemedical.com/news-brief/china-moves-to-expedite-clinical-trials-with-30-day-review-proposal/ 2025-07-07T18:23:17+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates/ 2025-07-07T18:23:04+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-updates-nhi-drug-reimbursement-policies-to-reinforce-drug-supply/ 2025-07-07T18:22:51+00:00 https://www.pacificbridgemedical.com/news-brief/vietnam-promulgates-new-regulations-to-streamline-drug-approval/ 2025-07-07T18:22:34+00:00 https://www.pacificbridgemedical.com/news-brief/japan-updates-pharmaceutical-and-medical-device-act-2025/ 2025-06-02T16:00:33+00:00 https://www.pacificbridgemedical.com/news-brief/more-unannounced-fda-inspections-in-china-and-india/ 2025-06-02T16:00:10+00:00 https://www.pacificbridgemedical.com/news-brief/japan-requires-excellent-clinical-data-for-higher-device-reimbursement/ 2025-06-02T15:59:55+00:00 https://www.pacificbridgemedical.com/news-brief/japan-solicits-more-western-drug-companies-to-alleviate-drug-lag/ 2025-06-02T15:58:56+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-drug-regulatory-updates/ 2025-06-02T15:58:40+00:00 https://www.pacificbridgemedical.com/news-brief/mhlw-official-explains-scope-of-expanded-conditional-approval-system/ 2025-06-02T15:58:26+00:00 https://www.pacificbridgemedical.com/news-brief/quick-asia-regulatory-updates-7/ 2025-06-02T15:58:13+00:00 https://www.pacificbridgemedical.com/news-brief/trade-frictions-with-china-open-the-door-wider-for-the-indian-medical-device-market/ 2025-06-02T15:58:02+00:00 https://www.pacificbridgemedical.com/news-brief/taiwan-government-to-provide-temporary-funding-for-new-cancer-drugs/ 2025-06-02T15:57:49+00:00 https://www.pacificbridgemedical.com/news-brief/japan-continues-to-update-its-drug-loss-problem/ 2025-05-05T14:28:24+00:00 https://www.pacificbridgemedical.com/news-brief/india-medical-device-regulatory-updates-2/ 2025-05-02T21:00:14+00:00 https://www.pacificbridgemedical.com/news-brief/korea-begins-implementing-immediate-market-entry-medical-technology-initiative/ 2025-05-02T21:00:10+00:00 https://www.pacificbridgemedical.com/news-brief/new-version-of-chinese-pharmacopoeia-published/ 2025-05-02T21:00:05+00:00 https://www.pacificbridgemedical.com/news-brief/japans-pmda-issues-guidance-on-determining-competing-products-in-drug-applications/ 2025-05-02T20:59:59+00:00 https://www.pacificbridgemedical.com/news-brief/asia-pacific-developing-frameworks-for-ai-enabled-medical-technologies/ 2025-05-02T20:59:49+00:00 https://www.pacificbridgemedical.com/news-brief/chinas-national-health-commission-releases-new-guideline-on-human-genetic-resources-management/ 2025-05-02T20:59:39+00:00 https://www.pacificbridgemedical.com/news-brief/china-outlines-pharmaceutical-draft-data-exclusivity-program/ 2025-05-02T20:59:33+00:00 https://www.pacificbridgemedical.com/news-brief/india-to-overhaul-cell-and-gene-therapy-regulatory-approach/ 2025-05-02T20:59:27+00:00 https://www.pacificbridgemedical.com/news-brief/philippines-fda-issues-draft-circular-to-improve-the-recall-system-for-health-products/ 2025-05-02T20:59:20+00:00 https://www.pacificbridgemedical.com/news-brief/urgently-needed-life-saving-therapies-for-singapore/ 2025-04-23T18:23:22+00:00 https://www.pacificbridgemedical.com/news-brief/growing-india-pharma-sector-seeks-freer-hand-from-government/ 2025-04-23T18:22:04+00:00 https://www.pacificbridgemedical.com/news-brief/148-new-drugs-to-be-eligible-for-insurance-reimbursement-in-china/ 2025-04-23T18:20:38+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-new-agency-to-support-review-innovative-convergence-products/ 2025-04-23T18:19:12+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-seeks-feedback-on-proposed-new-regulations-on-ngs-ivds/ 2025-04-23T18:16:43+00:00 https://www.pacificbridgemedical.com/news-brief/china-hospital-spending-on-cancer-drugs-grows/ 2025-04-23T18:15:12+00:00 https://www.pacificbridgemedical.com/news-brief/india-drafting-expanded-regulations-to-cover-all-medical-devices-on-market/ 2025-04-23T18:04:20+00:00 https://www.pacificbridgemedical.com/news-brief/drug-sales-to-japan-may-suffer-from-new-rules-pharma-leader-warns/ 2025-04-23T18:03:21+00:00 https://www.pacificbridgemedical.com/news-brief/south-korea-regulations-on-ivd-medical-devices-to-go-into-effect-in-2020/ 2025-04-23T18:01:27+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-fine-tunes-medical-device-labeling-requirements/ 2025-04-23T18:00:42+00:00 https://www.pacificbridgemedical.com/news-brief/china-updates-drug-regulations-seeks-comments-by-november-14/ 2025-04-23T17:59:26+00:00 https://www.pacificbridgemedical.com/news-brief/china-moves-to-better-regulate-clinical-trial-pharmaceutical-risks/ 2025-04-23T17:58:24+00:00 https://www.pacificbridgemedical.com/news-brief/china-takes-on-rare-diseases-prioritizing-research-drug-reimbursement/ 2025-04-23T17:56:59+00:00 https://www.pacificbridgemedical.com/news-brief/drug-firms-propose-alternative-to-draft-price-controls-in-the-philippines/ 2025-04-23T17:34:49+00:00 https://www.pacificbridgemedical.com/news-brief/china-approves-clinical-trials-at-more-than-150-new-hospitals-clinics/ 2025-04-23T17:31:19+00:00 https://www.pacificbridgemedical.com/news-brief/korea-eases-approval-licensing-review-of-ai-based-medical-devices/ 2025-04-23T17:30:33+00:00 https://www.pacificbridgemedical.com/news-brief/new-medical-device-requirements-under-consideration-in-malaysia/ 2025-04-23T17:28:32+00:00 https://www.pacificbridgemedical.com/news-brief/china-moves-to-implement-speedier-approvals-of-urgently-needed-drugs/ 2025-04-23T17:28:07+00:00 https://www.pacificbridgemedical.com/news-brief/singapore-releases-draft-of-proposed-regulatory-guidelines-on-software-based-medical-devices/ 2025-04-23T16:15:38+00:00 https://www.pacificbridgemedical.com/news-brief/china-to-institute-national-online-vaccine-tracking-system/ 2025-04-23T16:14:54+00:00 https://www.pacificbridgemedical.com/news-brief/malaysia-drafts-new-regulations-on-orphaned-medical-devices/ 2025-04-23T16:14:05+00:00